Atlas Trials

Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure Unit

Clinical trial NCT00637611 · COMPLETED

Trial details

NCT number
NCT00637611
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Seasonal Allergic Rhinitis
Start date
2003-02-01
Enrollment
1010

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.